Horizon Therapeutics Public Ltd Co

UBS Group AG

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/9/2023

Shares

534,044

Value ($000)

61,784

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/9/2023	61,784	0.0%	534,044	9/30/2023
2023 Q2	8/11/2023	60,621	0.0%	589,410	6/30/2023
2023 Q1	5/12/2023	29,262	0.0%	268,118	3/31/2023
2022 Q4	2/8/2023	48,016	0.0%	421,936	12/31/2022
2022 Q3	11/10/2022	35,595	0.0%	575,137	9/30/2022
2022 Q2	8/10/2022	37,729	0.0%	473,034	6/30/2022
2022 Q1	5/16/2022	54,253	0.0%	515,652	3/31/2022
2021 Q4	2/14/2022	68,487	0.0%	635,548	12/31/2021
2021 Q3	11/15/2021	62,216	0.0%	567,969	9/30/2021
2021 Q2	8/13/2021	34,729	0.0%	370,870	6/30/2021
2021 Q1	5/12/2021	39,735	0.0%	431,722	3/31/2021
2020 Q4	2/11/2021	59,673	0.0%	815,757	12/31/2020
2020 Q3	11/12/2020	21,384	0.0%	275,292	9/30/2020
2020 Q2	7/31/2020	7,452	0.0%	134,084	6/30/2020
2020 Q1	5/1/2020	8,922	0.0%	301,228	3/31/2020
2019 Q4	2/14/2020	7,729	0.0%	213,502	12/31/2019